PropThink: Lexicon’s Stock Offering; In Biotech, it’s Raise When You Can

[ACN Newswire] – By Jake KingDespite a stash of cash and liquid investments, Lexicon Pharmaceuticals (NASDAQ:LXRX) caught investors off guard two weeks ago by initiating a capital raise. The company had more than $225M … more

View todays social media effects on JNJ

View the latest stocks trending across Twitter. Click to view dashboard